Table 3.
Univariable analysis of 5-year disease-specific survival in patients with pancreatic neuroendocrine tumor.
| Variable | HR (95% CI) | p |
|---|---|---|
| Age (per year) | 1.06 (1.00–1.13) | 0.049 |
| Male sex | 0.59 (0.14–2.47) | 0.47 |
| LVI absent | Referent | - |
| LVI present | 14.68 (1.64–131.33) | 0.02 |
| T1/T2 | Referent | - |
| T3/T4 | 13.14 (1.58–109.19) | 0.02 |
| Node positive | 3.49 (0.87–13.98) | 0.08 |
| Grade 3 | Referent | - |
| Grade 2 | 0.04 (0.01–0.37) | 0.004 |
| Grade 1 | 0.02 (0.01–0.13) | <0.001 |
| R1 margin | 1.49 (0.18–12.10) | 0.71 |
| Minimally invasive approach | 0.61 (0.18–2.04) | 0.42 |
Abbreviations: HR = hazard ratio; CI = confidence interval; LVI = lymphovascular invasion.